Characterization and biological properties of a new staphylococcal exotoxin.

PubWeight™: 1.91‹?› | Rank: Top 3%

🔗 View Article (PMC 2191734)

Published in J Exp Med on November 01, 1994

Authors

K Ren1, J D Bannan, V Pancholi, A L Cheung, J C Robbins, V A Fischetti, J B Zabriskie

Author Affiliations

1: Laboratory of Bacterial Pathogenesis and Immunology, Rockefeller University, New York 10021.

Articles citing this

Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis (2008) 3.88

Multiplex PCR for detection of genes for Staphylococcus aureus enterotoxins, exfoliative toxins, toxic shock syndrome toxin 1, and methicillin resistance. J Clin Microbiol (2000) 3.59

Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. J Clin Microbiol (2003) 2.27

Identification and characterization of staphylococcal enterotoxin types G and I from Staphylococcus aureus. Infect Immun (1998) 2.22

Detection of seg, seh, and sei genes in Staphylococcus aureus isolates and determination of the enterotoxin productivities of S. aureus isolates Harboring seg, seh, or sei genes. J Clin Microbiol (2002) 2.16

Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever. J Clin Microbiol (1999) 2.08

Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1. Infect Immun (2000) 2.07

Crystal structure of the superantigen staphylococcal enterotoxin type A. EMBO J (1995) 1.99

Identification and characterization of novel superantigens from Streptococcus pyogenes. J Exp Med (1999) 1.98

Natural pathogens of laboratory mice, rats, and rabbits and their effects on research. Clin Microbiol Rev (1998) 1.88

Predominance and emergence of clones of hospital-acquired methicillin-resistant Staphylococcus aureus in Malaysia. J Clin Microbiol (2010) 1.73

Complete genome sequence of Macrococcus caseolyticus strain JCSCS5402, [corrected] reflecting the ancestral genome of the human-pathogenic staphylococci. J Bacteriol (2008) 1.61

Development of a single-reaction multiplex PCR toxin typing assay for Staphylococcus aureus strains. Appl Environ Microbiol (2000) 1.43

Identification and characterization of a new staphylococcal enterotoxin-related putative toxin encoded by two kinds of plasmids. Infect Immun (2003) 1.39

Mass outbreak of food poisoning disease caused by small amounts of staphylococcal enterotoxins A and H. Appl Environ Microbiol (2005) 1.18

Enterotoxigenic potential of Staphylococcus intermedius. Appl Environ Microbiol (2001) 1.18

Virulence genes and genotypic associations in nasal carriage, community-associated methicillin-susceptible and methicillin-resistant USA400 Staphylococcus aureus isolates. J Clin Microbiol (2010) 1.17

Staphylococcus aureus isolated in cases of impetigo produces both epidermolysin A or B and LukE-LukD in 78% of 131 retrospective and prospective cases. J Clin Microbiol (2001) 1.07

Characterization of the promoter elements for the staphylococcal enterotoxin D gene. J Bacteriol (2000) 1.04

Induction of emetic response to staphylococcal enterotoxins in the house musk shrew (Suncus murinus). Infect Immun (2003) 1.03

Biotyping of enterotoxigenic Staphylococcus aureus by enterotoxin gene cluster (egc) polymorphism and spa typing analyses. Appl Environ Microbiol (2006) 1.01

Emetic potentials of newly identified staphylococcal enterotoxin-like toxins. Infect Immun (2013) 0.95

Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections. Arthritis Res Ther (2006) 0.95

Biochemical and mutational analysis of the histidine residues of staphylococcal enterotoxin A. Infect Immun (1996) 0.88

Characterization of the canine type C enterotoxin produced by Staphylococcus intermedius pyoderma isolates. Infect Immun (1997) 0.85

Induction of emetic, pyrexic, and behavioral effects of Staphylococcus aureus enterotoxin B in the ferret. Infect Immun (2000) 0.82

Detection of enterotoxin genes of Staphylococcus SP isolated from nasal cavities and hands of food handlers. Braz J Microbiol (2010) 0.80

Staphylococcal enterotoxin H contrasts closely related enterotoxins in species reactivity. Immunology (2002) 0.79

Detection of the enterotoxigenic genes (sei,sej) in Staphylococcus aureus isolates from bovine mastitis milk in the West Azerbaijan of Iran. Comp Clin Path (2012) 0.78

Genetically divergent methicillin-resistant Staphylococcus aureus and sec-dependent mastitis of dairy goats in Taiwan. BMC Vet Res (2012) 0.76

Staphylococcal enterotoxin H induced apoptosis of bovine mammary epithelial cells in vitro. Toxins (Basel) (2014) 0.75

Enterotoxin gene profiles among Staphylococcus aureus isolated from raw milk. Iran J Vet Res (2014) 0.75

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71

Improved tools for biological sequence comparison. Proc Natl Acad Sci U S A (1988) 193.60

A new method for predicting signal sequence cleavage sites. Nucleic Acids Res (1986) 37.19

Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A (1981) 32.98

A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. Anal Biochem (1984) 22.53

The staphylococcal enterotoxins and their relatives. Science (1990) 11.99

Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet (1978) 10.25

High-copy-number and low-copy-number plasmid vectors for lacZ alpha-complementation and chloramphenicol- or kanamycin-resistance selection. Gene (1987) 9.16

Affinity purification of antibodies from diazotized paper blots of heterogeneous protein samples. J Biol Chem (1981) 9.11

Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis (1981) 8.40

The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell (1989) 7.02

Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc Natl Acad Sci U S A (1992) 6.95

Protein secretion in Escherichia coli. Annu Rev Microbiol (1985) 6.74

Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes. Infect Immun (1978) 3.01

Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet (1986) 2.69

Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J Exp Med (1992) 2.38

A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1. Infect Immun (1987) 2.13

Rapid, sensitive analysis of protein mixtures by mass spectrometry. Proc Natl Acad Sci U S A (1990) 1.96

Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR. Proc Natl Acad Sci U S A (1991) 1.71

Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody. Infect Immun (1990) 1.31

Immunological protection of rabbits infected with Staphylococcus aureus isolates from patients with toxic shock syndrome. Infect Immun (1986) 1.06

In vivo T-cell activation by staphylococcal enterotoxin B prevents outgrowth of a malignant tumor. Proc Natl Acad Sci U S A (1991) 1.06

Superantigens in human disease. Sci Am (1992) 1.01

Production of toxic shock syndrome-like illness in rabbits by Staphylococcus aureus D4508: association with enterotoxin A. Infect Immun (1990) 1.00

Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins. Proc Natl Acad Sci U S A (1992) 0.99

Articles by these authors

Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc Natl Acad Sci U S A (1992) 6.95

Sorting of protein A to the staphylococcal cell wall. Cell (1992) 6.48

Complete nucleotide sequence of type 6 M protein of the group A Streptococcus. Repetitive structure and membrane anchor. J Biol Chem (1986) 6.38

Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol (1999) 5.83

Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci U S A (1981) 5.56

An immunological relationship between the group. A streptococcus and mammalian muscle. J Exp Med (1966) 4.89

A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity. J Exp Med (1992) 4.60

Conservation of a hexapeptide sequence in the anchor region of surface proteins from gram-positive cocci. Mol Microbiol (1990) 4.50

A method to isolate RNA from gram-positive bacteria and mycobacteria. Anal Biochem (1994) 4.24

Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci U S A (1988) 3.82

Group A streptococcal antigens cross-reactive with myocardium. Purification of heart-reactive antibody and isolation and characterization of the streptococcal antigen. J Exp Med (1977) 3.80

Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science (2001) 3.72

Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein. J Exp Med (1984) 3.69

The molecular architecture of the sar locus in Staphylococcus aureus. J Bacteriol (1996) 3.46

Size variation of the M protein in group A streptococci. J Exp Med (1985) 3.45

alpha-enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci. J Biol Chem (1998) 3.37

Size variation in group A streptococcal M protein is generated by homologous recombination between intragenic repeats. Mol Gen Genet (1987) 3.32

Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein. J Exp Med (1985) 3.23

Variation in the expression of cell wall proteins of Staphylococcus aureus grown on solid and liquid media. Infect Immun (1988) 3.21

SarA, a global regulator of virulence determinants in Staphylococcus aureus, binds to a conserved motif essential for sar-dependent gene regulation. J Biol Chem (1999) 3.11

Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci U S A (2001) 3.10

Molecular interactions between two global regulators, sar and agr, in Staphylococcus aureus. J Biol Chem (1998) 3.09

Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol (2000) 3.08

Characterization of the sar locus and its interaction with agr in Staphylococcus aureus. J Bacteriol (1996) 3.05

Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med (1976) 2.98

Conversion of an M- group A streptococcus to M+ by transfer of a plasmid containing an M6 gene. J Exp Med (1986) 2.89

Streptococcal M protein extracted by nonionic detergent. I. Properties of the antiphagocytic and type-specific molecules. J Exp Med (1976) 2.77

Tropomyosin-like seven residue periodicity in three immunologically distinct streptococal M proteins and its implications for the antiphagocytic property of the molecule. J Exp Med (1980) 2.75

Purification and physical properties of group C streptococcal phage-associated lysin. J Exp Med (1971) 2.67

The sae locus of Staphylococcus aureus controls exoprotein synthesis at the transcriptional level. Arch Microbiol (1997) 2.65

Heart-reactive antibody associated with rheumatic fever: characterization and diagnostic significance. Clin Exp Immunol (1970) 2.62

Studies on group A streptococcal M-proteins: purification of type 5 M-protein and comparison of its amino terminal sequence with two immunologically unrelated M-protein molecules. J Immunol (1980) 2.62

Expression of streptococcal M protein in Escherichia coli. Science (1983) 2.57

Staphylococcus aureus RN6390 replicates and induces apoptosis in a pulmonary epithelial cell line. Infect Immun (2000) 2.54

Evaluation of a tetracycline-inducible promoter in Staphylococcus aureus in vitro and in vivo and its application in demonstrating the role of sigB in microcolony formation. Infect Immun (2001) 2.49

Transcriptional analysis of different promoters in the sar locus in Staphylococcus aureus. J Bacteriol (1998) 2.48

The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci. J Exp Med (1988) 2.42

The complete amino acid sequence of a biologically active 197-residue fragment of M protein isolated from type 5 group A streptococci. J Biol Chem (1984) 2.40

Isolation and characterization of the cell-associated region of group A streptococcal M6 protein. J Bacteriol (1988) 2.35

Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect Immun (1988) 2.24

Relationship of M protein genes in group A streptococci. Proc Natl Acad Sci U S A (1985) 2.24

Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J Exp Med (1989) 2.15

Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis. Infect Immun (1997) 2.13

Streptococcal M protein extracted by nonionic detergent. II. Analysis of the antibody response to the multiple antigenic determinants of the M-protein molecule. J Exp Med (1977) 2.13

Electron microscopic studies of human glomerulonephritis with ferritin-conjugated antibody. Localization of antigen-antibody complexes in glomerular structures of patients with acute glomerulonephritis. J Exp Med (1966) 2.11

SarA level is a determinant of agr activation in Staphylococcus aureus. Mol Microbiol (1998) 2.09

Immunochemical localization and amino acid sequences of crossreactive epitopes within the group A streptococcal M6 protein. J Exp Med (1986) 2.03

Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science (1998) 2.02

Characterization of sarR, a modulator of sar expression in Staphylococcus aureus. Infect Immun (2001) 2.01

Characterization of RAT, an autolysis regulator in Staphylococcus aureus. Mol Microbiol (2003) 2.01

DNA sequence of the serum opacity factor of group A streptococci: identification of a fibronectin-binding repeat domain. Infect Immun (1995) 1.91

SarT, a repressor of alpha-hemolysin in Staphylococcus aureus. Infect Immun (2001) 1.89

Homologous regions within M protein genes in group A streptococci of different serotypes. Infect Immun (1986) 1.85

Transport systems for alanine, serine, and glycine in Escherichia coli K-12. J Bacteriol (1973) 1.85

Mimetic relationships between group A streptococci and mammalian tissues. Adv Immunol (1967) 1.83

Influence of agr on fibrinogen binding in Staphylococcus aureus Newman. Infect Immun (1996) 1.81

Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc Natl Acad Sci U S A (1995) 1.80

Requirements for the opsonic activity of human IgG directed to type 6 group A streptococci: net basic charge and intact Fc region. J Immunol (1983) 1.79

Sequence and structural characteristics of the trypsin-resistant T6 surface protein of group A streptococci. J Bacteriol (1990) 1.78

Identification of an endogenous membrane anchor-cleaving enzyme for group A streptococcal M protein. Its implication for the attachment of surface proteins in gram-positive bacteria. J Exp Med (1989) 1.77

Glyceraldehyde-3-phosphate dehydrogenase on the surface of group A streptococci is also an ADP-ribosylating enzyme. Proc Natl Acad Sci U S A (1993) 1.76

Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells. J Clin Invest (1991) 1.73

Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins. Infect Immun (1997) 1.72

Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone. Biochem Biophys Res Commun (1985) 1.71

Presence of two distinct regions in the coiled-coil structure of the streptococcal Pep M5 protein: relationship to mammalian coiled-coil proteins and implications to its biological properties. Proc Natl Acad Sci U S A (1985) 1.68

The role of fibrinogen in staphylococcal adherence to catheters in vitro. J Infect Dis (1990) 1.64

Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway. J Exp Med (1976) 1.64

sigma(B) activity in Staphylococcus aureus is controlled by RsbU and an additional factor(s) during bacterial growth. Infect Immun (2001) 1.63

Purification and partial characterization of the nephritis strain-associated protein from Streptococcus pyogenes, group A. J Exp Med (1986) 1.62

Immunochemical analysis of intact M protein secreted from cell wall-less streptococci. Infect Immun (1981) 1.62

Spontaneous M6 protein size mutants of group A streptococci display variation in antigenic and opsonogenic epitopes. Proc Natl Acad Sci U S A (1988) 1.62

Antigens in Streptococcus mutans cross reactive with human heart muscle. J Dent Res (1976) 1.59

A suppression of cellular immunity in patients with multiple sclerosis. J Exp Med (1973) 1.55

Cell wall anchoring of the Streptococcus pyogenes M6 protein in various lactic acid bacteria. J Bacteriol (1997) 1.55

Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades. Pediatr Infect Dis J (1998) 1.54

A human IgG receptor of group A streptococci is associated with tissue site of infection and streptococcal class. J Infect Dis (1990) 1.53

Nucleotide sequences of two adjacent M or M-like protein genes of group A streptococci: different RNA transcript levels and identification of a unique immunoglobulin A-binding protein. Infect Immun (1992) 1.53

Differentiation between two biologically distinct classes of group A streptococci by limited substitutions of amino acids within the shared region of M protein-like molecules. J Exp Med (1990) 1.52

Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains. Antimicrob Agents Chemother (2003) 1.51

Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus. Infect Immun (1997) 1.51

Evidence for group A-related M protein genes in human but not animal-associated group G streptococcal pathogens. Microb Pathog (1987) 1.51

Cloning, expression, and nucleotide sequence of a Staphylococcus aureus gene (fbpA) encoding a fibrinogen-binding protein. Infect Immun (1995) 1.50

Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes. J Immunol (1990) 1.50

Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc Natl Acad Sci U S A (1992) 1.49

Crystal structure of the SarR protein from Staphylococcus aureus. Proc Natl Acad Sci U S A (2001) 1.48

Factors affecting the collagen binding capacity of Staphylococcus aureus. Infect Immun (1998) 1.48

Induction of lysogenic bacteriophage and phage-associated toxin from group a streptococci during coculture with human pharyngeal cells. Infect Immun (2001) 1.46

Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis. Infect Immun (1996) 1.45

Location of the complement factor H binding site on streptococcal M6 protein. Infect Immun (1995) 1.44

A 21-kDa surface protein of Mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion. Proc Natl Acad Sci U S A (1999) 1.44

A highly conserved region present in transcripts encoding heterologous M proteins of group A streptococci. Infect Immun (1987) 1.40

Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A. J Exp Med (1988) 1.39

Clumping factor A mediates binding of Staphylococcus aureus to human platelets. Infect Immun (2001) 1.39

Biological and immunochemical identity of M protein on group G streptococci with M protein on group A streptococci. Infect Immun (1987) 1.39

Lymphocytic responses to streptococcal antigens in glomerulonephritic patients. Science (1970) 1.39

Amino acid sequence and physicochemical similarities between streptococcal M protein and mammalian tropomyosin. Proc Natl Acad Sci U S A (1979) 1.38

Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains. Infect Immun (1995) 1.36